BridgeMD
New treatment option for Stroke
Official title Acquired Dyslexia Modeling and Treatment
ClinicalTrials.gov ID: NCT07209488
What this study is testing
- What it's testing
- This study is a low-risk, early phase 1, multicenter trial to test the use of a computational (neural network) cognitive model of reading to simulate acquired dyslexia and its treatment. The aim is to determine whether there is an advantage to receiving the treatment the model predicts to be advantageous compared to the alternative treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Fluent in English as a first language pre-stroke by self report.
- Normal or corrected-to-normal vision.
- Normal or aided hearing.
- Left hemisphere ischemic or hemorrhagic stroke (as verified by a structural brain scan).
- Impaired reading as confirmed by significant impairment in the Basic Skills cluster of the Woodcock Reading Mastery Test - III.
You likely can't join if
- Diagnosed pre-stroke neurological disease affecting the brain other than left hemisphere stroke.
- Severe apraxia of speech (determined by consensus judgment among speech-language pathologists).
- History of learning disabilities such as developmental dyslexia or current self-reported major psychiatric disorders.
- Inability to undergo, or provide a copy of, a post-stroke brain imaging scan.
The study team makes the final eligibility decision.
Where it's taking place
- Tallahassee, Florida, United States
- Baltimore, Maryland, United States
- West Orange, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tallahassee, Florida, United States; Baltimore, Maryland, United States; West Orange, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.